Suchergebnisse - "Smyth, E"

PubPharm (7)

1

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma : EMERGE

enthalten in: ESMO open | 2024

von Cartwright, E. | Slater, S. | Saffery, C. | +17

2

Controversies in upper GI oncology : MSI-H in gastroesophageal adenocarcinoma

enthalten in: ESMO open | 2024

von Petrillo, A. | Derks, S. | Smyth, E.

3

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

enthalten in: ESMO open | 2024

von Shitara, K. | Fleitas, T. | Kawakami, H. | +29

4

ESMO Congress 2021 : highlights from the EORTC gastrointestinal tract cancer group's perspective

enthalten in: ESMO open | 2022

von Koessler, T. | Alsina, M. | Arnold, D. | +13

5

Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma : a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score

enthalten in: ESMO open | 2022

von Leone, A. | Petrelli, F. | Ghidini, A. | +3

6

ESMO20 YO for YO : highlights on upper GI tumours

enthalten in: ESMO open | 2021

von Cardone, C. | Pihlak, R. | Smyth, E.

7

Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer : a meta-analysis of randomized clinical trials

enthalten in: ESMO open | 2021

von Pietrantonio, F. | Randon, G. | Di Bartolomeo, M. | +4

1
[1]